NCT06689150View on ClinicalTrials.gov

Evaluation of the Contraceptive Efficacy

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 10, 2024

Conditions
Menstrual Bleeding, Heavy
Interventions
DRUG

Drospinetta

To evaluate the three different types of POPs, the new POPs Drosperinon 4 mg, Desogestrel 75 pg, and Levonorgestrel 30 pg in healthy female subjects as regard to the contraceptive efficacy, bleeding pattern, acceptability and safety

Trial Locations (1)

Unknown

Al-Azhar University Hospitals, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT06689150 - Evaluation of the Contraceptive Efficacy | Biotech Hunter | Biotech Hunter